1
|
Kalyanakrishnan K, Beaudin A, Jetté A, Ghezelbash S, Hotea DI, Chen J, Lefrançois P, Laurin M. ARHGEF3 Regulates Hair Follicle Morphogenesis. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.09.13.612256. [PMID: 39314354 PMCID: PMC11419159 DOI: 10.1101/2024.09.13.612256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 09/25/2024]
Abstract
During embryogenesis, cells arrange into precise patterns that enable tissues and organs to develop specialized functions. Despite its critical importance, the molecular choreography behind these collective cellular behaviors remains elusive, posing a major challenge in developmental biology and limiting advances in regenerative medicine. By using the mouse hair follicle as a mini-organ system to study the formation of bud-like structures during embryonic development, our work uncovers a crucial role for the Rho GTPase regulator ARHGEF3 in hair follicle morphogenesis. We demonstrate that Arhgef3 expression is upregulated at the onset of hair follicle placode formation. In Arhgef3 knockout animals, we observed defects in placode compaction, leading to impaired hair follicle downgrowth. Through cell culture models, we show that ARHGEF3 promotes F-actin accumulation at the cell cortex and P-cadherin enrichment at cell-cell junctions. Collectively, our study identifies ARHGEF3 as a new regulator of cell shape rearrangements during hair placode morphogenesis, warranting further exploration of its role in other epithelial appendages that arise from similar developmental processes.
Collapse
Affiliation(s)
- Krithika Kalyanakrishnan
- Centre de recherche du CHU de Québec - Université Laval, axe Oncologie, Québec, Canada
- Programme de biologie moléculaire et cellulaire, Université Laval
- Département de biologie moléculaire, biochimie médicale et pathologie, Université Laval
- Faculté de médecine, Université Laval
- Centre de recherche sur le cancer de l'Université Laval (CRC)
- Centre de recherche en organogénèse expérimentale (LOEX)
| | - Amy Beaudin
- Centre de recherche du CHU de Québec - Université Laval, axe Oncologie, Québec, Canada
- Programme de biologie moléculaire et cellulaire, Université Laval
- Département de biologie moléculaire, biochimie médicale et pathologie, Université Laval
- Faculté de médecine, Université Laval
- Centre de recherche sur le cancer de l'Université Laval (CRC)
- Centre de recherche en organogénèse expérimentale (LOEX)
| | - Alexandra Jetté
- Centre de recherche du CHU de Québec - Université Laval, axe Oncologie, Québec, Canada
- Centre de recherche sur le cancer de l'Université Laval (CRC)
- Centre de recherche en organogénèse expérimentale (LOEX)
| | - Sarah Ghezelbash
- Cancer Axis, Lady Davis Institute for Medical Research, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Québec, Canada
| | - Diana Ioana Hotea
- Centre de recherche du CHU de Québec - Université Laval, axe Oncologie, Québec, Canada
- Programme de biologie moléculaire et cellulaire, Université Laval
- Département de biologie moléculaire, biochimie médicale et pathologie, Université Laval
- Faculté de médecine, Université Laval
- Centre de recherche sur le cancer de l'Université Laval (CRC)
- Centre de recherche en organogénèse expérimentale (LOEX)
| | - Jie Chen
- Department of Cell & Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA
- Department of Biomedical and Translational Sciences, Carle Illinois College of Medicine, Urbana, IL 61801
| | - Philippe Lefrançois
- Cancer Axis, Lady Davis Institute for Medical Research, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Québec, Canada
- Division of Dermatology, Department of Medicine, McGill University, Montréal, QC, Canada
| | - Mélanie Laurin
- Centre de recherche du CHU de Québec - Université Laval, axe Oncologie, Québec, Canada
- Programme de biologie moléculaire et cellulaire, Université Laval
- Département de biologie moléculaire, biochimie médicale et pathologie, Université Laval
- Faculté de médecine, Université Laval
- Centre de recherche sur le cancer de l'Université Laval (CRC)
- Centre de recherche en organogénèse expérimentale (LOEX)
| |
Collapse
|
2
|
Schauer A, Pranjic-Ferscha K, Hauschild R, Heisenberg CP. Robust axis elongation by Nodal-dependent restriction of BMP signaling. Development 2024; 151:dev202316. [PMID: 38372390 PMCID: PMC10911127 DOI: 10.1242/dev.202316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Accepted: 01/04/2024] [Indexed: 02/20/2024]
Abstract
Embryogenesis results from the coordinated activities of different signaling pathways controlling cell fate specification and morphogenesis. In vertebrate gastrulation, both Nodal and BMP signaling play key roles in germ layer specification and morphogenesis, yet their interplay to coordinate embryo patterning with morphogenesis is still insufficiently understood. Here, we took a reductionist approach using zebrafish embryonic explants to study the coordination of Nodal and BMP signaling for embryo patterning and morphogenesis. We show that Nodal signaling triggers explant elongation by inducing mesendodermal progenitors but also suppressing BMP signaling activity at the site of mesendoderm induction. Consistent with this, ectopic BMP signaling in the mesendoderm blocks cell alignment and oriented mesendoderm intercalations, key processes during explant elongation. Translating these ex vivo observations to the intact embryo showed that, similar to explants, Nodal signaling suppresses the effect of BMP signaling on cell intercalations in the dorsal domain, thus allowing robust embryonic axis elongation. These findings suggest a dual function of Nodal signaling in embryonic axis elongation by both inducing mesendoderm and suppressing BMP effects in the dorsal portion of the mesendoderm.
Collapse
Affiliation(s)
- Alexandra Schauer
- Institute of Science and Technology Austria, Klosterneuburg 3400, Austria
| | | | - Robert Hauschild
- Institute of Science and Technology Austria, Klosterneuburg 3400, Austria
| | | |
Collapse
|
3
|
Park JE, Kim JH, Park JY, Jun SH, Shin HJ. A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge. Virol J 2022; 19:112. [PMID: 35761402 PMCID: PMC9235161 DOI: 10.1186/s12985-022-01844-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Accepted: 06/20/2022] [Indexed: 11/30/2022] Open
Abstract
Background Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory disease in humans, with a case fatality rate of approximately 35%, thus posing a considerable threat to public health. The lack of approved vaccines or antivirals currently constitutes a barrier in controlling disease outbreaks and spread. Methods In this study, using a mammalian expression system, which is advantageous for maintaining correct protein glycosylation patterns, we constructed chimeric MERS-CoV virus-like particles (VLPs) and determined their immunogenicity and protective efficacy in mice. Results Western blot and cryo-electron microscopy analyses demonstrated that MERS-CoV VLPs were efficiently produced in cells co-transfected with MERS-CoV spike (S), envelope, membrane and murine hepatitis virus nucleocapsid genes. We examined their ability as a vaccine in a human dipeptidyl peptidase 4 knock-in C57BL/6 congenic mouse model. Mice immunized with MERS VLPs produced S-specific antibodies with virus neutralization activity. Furthermore, MERS-CoV VLP immunization provided complete protection against a lethal challenge with mouse-adapted MERS-CoV and improved virus clearance in the lung. Conclusions Overall, these data demonstrate that MERS-CoV VLPs have excellent immunogenicity and represent a promising vaccine candidate.
Collapse
Affiliation(s)
- Jung-Eun Park
- Laboratory of Veterinary Public Health, College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea. .,Research Institute of Veterinary Research, Chungnam National University, Daejeon, 34134, Republic of Korea.
| | - Ji-Hee Kim
- Laboratory of Veterinary Public Health, College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea
| | - Jae-Yeon Park
- Laboratory of Veterinary Infectious Diseases, College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea
| | - Sung-Hoon Jun
- Electron Microscopy & Spectroscopy Team, Korea Basic Science Institute, Cheongju, Chungcheongbukdo, 28119, Republic of Korea
| | - Hyun-Jin Shin
- Laboratory of Veterinary Infectious Diseases, College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea. .,Research Institute of Veterinary Research, Chungnam National University, Daejeon, 34134, Republic of Korea.
| |
Collapse
|